Your browser doesn't support javascript.
loading
Case of both rivaroxaban- and dabigatran-induced leukocytoclastic vasculitis, during management of pulmonary thromboembolism.
Lee, Hong Lyeol; Kim, Lucia; Kim, Cheol Woo; Kim, Jung Soo; Nam, Hae Sung; Ryu, Jeong Seon.
Affiliation
  • Lee HL; Department of Internal Medicine, Inha University College of Medicine, South Korea.
  • Kim L; Department of Internal Pathology, Inha University College of Medicine, South Korea.
  • Kim CW; Department of Internal Medicine, Inha University College of Medicine, South Korea.
  • Kim JS; Department of Internal Medicine, Inha University College of Medicine, South Korea.
  • Nam HS; Department of Internal Medicine, Inha University College of Medicine, South Korea.
  • Ryu JS; Department of Internal Medicine, Inha University College of Medicine, South Korea.
Respir Med Case Rep ; 26: 219-222, 2019.
Article in En | MEDLINE | ID: mdl-30740299
Leukocytoclastic vasculitis is a disorder characterized by neutrophilic inflammation that is predominantly limited to the superficial cutaneous postcapillary venules. This condition may be idiopathic or may have a defined cause. Rivaroxaban and dabigatran have been widely used as warfarin alternatives, because of their efficacy and safety. In this case report, we describe a case of leukocytoclastic vasculitis induced by both rivaroxaban- and dabigatran-, which developed during the management of pulmonary thromboembolism.
Key words

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: Respir Med Case Rep Year: 2019 Document type: Article Affiliation country: Korea (South) Country of publication: United kingdom

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: Respir Med Case Rep Year: 2019 Document type: Article Affiliation country: Korea (South) Country of publication: United kingdom